University of Ulster-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Ulster - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013557
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Ulster (UU) is an educational service provider that offers undergraduate and postgraduate educational programs. The university’s business activities include teaching and learning, research and innovation, widening access to education, and technology and knowledge transfer. Its business services include continuing personal and professional development programmes and consultancy services. UU also provides part time, short time, and full time educational programs. The university offers courses in the field of arts, computing and engineering, life and health sciences, social sciences, business management, and art, design and the built environment. It operates through the campuses located in Belfast, Coleraine, Jordanstown, Magee, Birmingham and London. UU is headquartered in Coleraine, the UK.

University of Ulster – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Ulster, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Ulster, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Ulster, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Ulster, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Ulster, Medical Devices Deals, 2011 to YTD 2017 9
University of Ulster, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Ulster, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
SiSaf Raises USD0.6 Million in Venture Financing 11
SiSaf Raises USD0.8 Million in Venture Financing 12
SiSaf Raises USD1 Million in Financing Round 13
Partnerships 14
Avellino Labs Enters into Co-Development Agreement with Ulster University 14
McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 15
UMass Enters Into An Agreement With UOT, Tampere Institute, VTT, University Of Ulster And Queen’s University 16
University of Ulster – Key Competitors 18
University of Ulster – Key Employees 19
University of Ulster – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Apr 05, 2017: Ulster University research set to combat antibiotic resistance for acne treatment 21
Jan 06, 2017: New Ulster University pancreatic cancer research set to further revolutionise treatment options 22
Jan 05, 2017: Ulster University wins landmark €23 million of EU cross-border funding for research and innovation 23
Feb 08, 2016: World First Research Takes Step Towards Uncovering Cause of Down Syndrome Vision Problems in Children 24
Product News 25
Jun 08, 2016: Bubbly drinks inspire more effective cancer treatment 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
University of Ulster, Pharmaceuticals & Healthcare, Key Facts 2
University of Ulster, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Ulster, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Ulster, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Ulster, Deals By Therapy Area, 2011 to YTD 2017 8
University of Ulster, Medical Devices Deals, 2011 to YTD 2017 9
University of Ulster, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
SiSaf Raises USD0.6 Million in Venture Financing 11
SiSaf Raises USD0.8 Million in Venture Financing 12
SiSaf Raises USD1 Million in Financing Round 13
Avellino Labs Enters into Co-Development Agreement with Ulster University 14
McClay Foundation, Almac Discovery and University of Ulster Enter into Research Agreement 15
UMass Enters Into An Agreement With UOT, Tampere Institute, VTT, University Of Ulster And Queen's University 16
University of Ulster, Key Competitors 18
University of Ulster, Key Employees 19
University of Ulster, Other Locations 20
University of Ulster, Subsidiaries 20

★海外企業調査レポート[University of Ulster-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sainsbury’s Bank plc:企業の戦略・SWOT・財務情報
    Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report Summary Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lightbridge Corporation (LTBR)-エネルギー分野:企業M&A・提携分析
    Summary Lightbridge Corporation (Lightbridge) is a nuclear fuel technology company, which develops thorium based nuclear fuel technologies for nuclear reactor systems, that increases the power output of commercial reactors; generates nuclear energy and the amount of nuclear waste on a per-megawatt-h …
  • Gerdau S.A. (GGBR4):企業の財務・戦略的SWOT分析
    Gerdau S.A. (GGBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive inform …
  • Genetic Analysis AS:医療機器:M&Aディール及び事業提携情報
    Summary Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and ba …
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • GE Energy Power Conversion Group:企業の戦略的SWOT分析
    GE Energy Power Conversion Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Generali Brasil Seguros S.A.:企業の戦略・SWOT・財務情報
    Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析
    Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Revolution Medicines Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revolution Medicines Inc (Revolution Medicines) is a drug development company that discovers and develops new medicines and therapies for cancer patients. The company’s programs include SHP2 Program, 4EBP1 Program and mTORC1 Program. It develops REVBLOCKS platform, an integrated suite of mod …
  • Dr. August Oetker KG:戦略・SWOT・企業財務分析
    Dr. August Oetker KG - Strategy, SWOT and Corporate Finance Report Summary Dr. August Oetker KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JBCC Holdings Inc (9889):企業の財務・戦略的SWOT分析
    JBCC Holdings Inc (9889) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • RHI Magnesita N.V.:企業の戦略・SWOT・財務情報
    RHI Magnesita N.V. - Strategy, SWOT and Corporate Finance Report Summary RHI Magnesita N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Animal Health International Inc:企業の戦略的SWOT分析
    Animal Health International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析
    Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務分析
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bharat Petroleum Corporation Limited:企業の戦略・SWOT・財務分析
    Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Petroleum Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • Colonial Group Inc.:企業の戦略・SWOT・財務分析
    Colonial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Colonial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NCsoft Corp (036570):企業の財務・戦略的SWOT分析
    NCsoft Corp (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆